Lactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut

Journal of Mammary Gland Biology and Neoplasia

Volumn 20, Issue 3-4, 2015, Pages 149-158

  Goldsmith, Felicia ^a   O’Sullivan, Aifric ^b   Smilowitz, Jennifer T ^a   Freeman, Samara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

B.infantis; Bifidobacterium longum subspecies infantis; Breast milk; Glycans; Microbiome; Phenotype

Indexed keywords

GLYCAN; GLYCOSYLATED PROTEIN; MILK PROTEIN; IMMUNOGLOBULIN; POLYSACCHARIDE;

BIRTH; BREAST MILK; DIET; GENOTYPE; HUMAN; INTESTINE FLORA; MICROBIOME; MILK ORIENTED MICROBIOME; MILK ORIENTED MICROBIOTA; PHENOTYPE; REVIEW; BIFIDOBACTERIUM; BREAST FEEDING; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

BIFIDOBACTERIUM; BREAST FEEDING; DIET; HUMANS; IMMUNOGLOBULINS; INTESTINES; MICROBIOTA; MILK, HUMAN; POLYSACCHARIDES;

EID: 84947045026     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-015-9335-2     Document Type: Review

References (107)

1. Zivkovic AM, Lewis ZT, German JB, Mills DA. Establishment of a milk-oriented microbiota (MOM) in early life: how babies meet their MOMs. Funct Food Rev. 2013;5(1):3–12.
2. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5(7):e177. doi:10.1371/journal.pbio.0050177.
3. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009;98(2):229–38. doi:10.1111/j.1651-2227.2008.01060.x.
4. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–21. doi:10.1542/peds.2005-2824.
5. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin N Am. 2013;60(1):49–74. doi:10.1016/j.pcl.2012.10.002.
6. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23. doi:10.1073/pnas.0407076101.
7. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. doi:10.1038/4441022a.
8. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–31. doi:10.1038/nature05414.
9. Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27(2):201–14. doi:10.1177/0884533611436116.
10. Gordon JI, Dewey KG, Mills DA, Medzhitov RM. The human gut microbiota and undernutrition. Sci Transl Med. 2012;4(137):137ps12. doi:10.1126/scitranslmed.3004347.
11. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24(2):160–8. doi:10.1016/j.copbio.2012.08.005.
12. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94(1):58–65. doi:10.3945/ajcn.110.010132.
13. Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol Immunol. 1995;39(8):555–62.
14. Arboleya S, Bahrami B, Macfarlane S, Gueimonde M, Macfarlane GT, de Los Reyes-Gavilan CG. Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota. Benefic Microbes. 2015;1–10. doi: 10.3920/bm2014.0111.
15. Maranduba CM, De Castro SB, de Souza GT, Rossato C. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. 2015;2015:931574.
16. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4(6):478–85. doi:10.1038/nri1373.
17. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688–93. doi:10.1038/sj.embor.7400731.
18. McVey Neufeld KA, Mao YK, Bienenstock J, Foster JA, Kunze WA. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol Motil. 2013;25(2):183–e88. doi:10.1111/nmo.12049.
19. Bager P, Simonsen J, Nielsen NM, Frisch M. Cesarean section and offspring’s risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis. 2012;18(5):857–62. doi:10.1002/ibd.21805.
20. Bager P, Wohlfahrt J, Westergaard T. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin Exp Allergy. 2008;38(4):634–42. doi:10.1111/j.1365-2222.2008.02939.x.
21. Pei Z, Heinrich J, Fuertes E, Flexeder C, Hoffmann B, Lehmann I, et al. Cesarean delivery and risk of childhood obesity. J Pediatr. 2014;164(5):1068–73.e2. doi:10.1016/j.jpeds.2013.12.044.
22. Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010;156:3329–41. doi:10.1099/Mic.0.043224-0.
23. Sela DA, Mills DA. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol. 2010;18(7):298–307. doi:10.1016/j.tim.2010.03.008.
24. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol. 2006;72(6):4497–9. doi:10.1128/AEM.02515-05.
25. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res. 2007;51(11):1398–405. doi:10.1002/mnfr.200700150.
26. LoCascio RG, Niñonuevo MR, Kronewitter SR, Freeman SL, German JB, Lebrilla CB, et al. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol. 2009;2(3):333–42. doi:10.1111/j.1751-7915.2008.00072.x.
27. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, et al. The genome sequence of Bifidobacterium longum subsp infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A. 2008;105(48):18964–9. doi:10.1073/pnas.0809584105.
28. LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl Environ Microbiol. 2010;76(22):7373–81. doi:10.1128/aem.00675-10.
29. Sela DA, Mills DA. The marriage of nutrigenomics with the microbiome: the case of infant-associated bifidobacteria and milk. Am J Clin Nutr. 2014;99(3):697s–703. doi:10.3945/ajcn.113.071795.
30. Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, Raqib R, et al. Stool microbiota and vaccine responses of infants. Pediatrics. 2014;134(2):e362–72. doi:10.1542/peds.2013-3937.
31. Underwood MA, Arriola J, Gerber CW, Kaveti A, Kalanetra KM, Kananurak A, et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res. 2014. doi:10.1038/pr.2014.102.
32. Underwood MA, Salzman NH, Bennett SH, Barman M, Mills DA, Marcobal A, et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr. 2009;48(2):216–25. doi:10.1097/MPG.0b013e31818de195.
33. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055–62. doi:10.1542/peds.2013-1339.
34. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr. 2009;55(2):128–31. doi:10.1093/tropej/fmn091.
35. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1–4. doi:10.1542/peds.2004-1463.
36. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5–9. doi:10.1136/archdischild-2011-300435.
37. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192–6. doi:10.1016/j.jpeds.2005.03.054.
38. Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr. 2010;51(2):203–9. doi:10.1097/MPG.0b013e3181dc0d93.
39. Unger S, Stintzi A, Shah P, Mack D, O’Connor DL. Gut microbiota of the very-low-birth-weight infant. Pediatr Res. 2015;77(1–2):205–13. doi:10.1038/pr.2014.162.
40. Taft DH, Ambalavanan N, Schibler KR, Yu Z, Newburg DS, Ward DV, et al. Intestinal microbiota of preterm infants differ over time and between hospitals. Microbiome. 2014;2:36. doi:10.1186/2049-2618-2-36.
41. Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr. 2006;25(3):361–8. doi:10.1016/j.clnu.2006.03.002.
42. Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert JA. Development of the preterm infant gut microbiome: a research priority. Microbiome. 2014;2:38. doi:10.1186/2049-2618-2-38.
43. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–5. doi:10.1073/pnas.1002601107.
44. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7. doi:10.1038/nature11053.
45. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl. 2003;91(441):48–55.
46. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr. 2008;138(9):1796S–800.
47. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, Mai V. Intestinal microbial ecology in premature infants assessed using non-culture based techniques. J Pediatr. 2010;156(1):20–5. doi:10.1016/j.jpeds.2009.06.063.
48. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3(8):944–54. doi:10.1038/ismej.2009.37.
49. La Rosa PS, Warner BB, Zhou Y, Weinstock GM, Sodergren E, Hall-Moore CM, et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci U S A. 2014;111(34):12522–7. doi:10.1073/pnas.1409497111.
50. Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics. 2007;119(3):e724–32. doi:10.1542/peds.2006-1649.
51. Martin R, Jimenez E, Heilig H, Fernandez L, Marin ML, Zoetendal EG, et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol. 2009;75(4):965.
52. Grönlund MM, Gueimonde M, Laitinen K, Kociubinski G, Grönroos T, Salminen S, et al. Maternal breast‐milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy. 2007;37(12):1764–72.
53. Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr. 2013;110(7):1253–62. doi:10.1017/s0007114513000597.
54. Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754–8. doi:10.1016/j.jpeds.2003.09.028.
55. Delgado S, Arroyo R, Martin R, Rodriguez JM. PCR-DGGE assessment of the bacterial diversity of breast milk in women with lactational infectious mastitis. BMC Infect Dis. 2008;8:51. doi:10.1186/1471-2334-8-51.
56. Delgado S, Arroyo R, Jimenez E, Marin ML, del Campo R, Fernandez L, et al. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol. 2009;9:82. doi:10.1186/1471-2180-9-82.
57. Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One. 2011;6(6):e21313. doi:10.1371/journal.pone.0021313.
58. Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80(10):3007–14.
59. Jost T, Lacroix C, Braegger CP, Rochat F, Chassard C. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environ Microbiol. 2013. doi:10.1111/1462-2920.12238.
60. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190–2. doi:10.1126/science.1171700.
61. D’Amico CJ, DiNardo CA, Krystofiak S. Preventing contamination of breast pump kit attachments in the NICU. J Perinat Neonatal Nurs. 2003;17(2):150–7.
62. Cephas KD, Kim J, Mathai RA, Barry KA, Dowd SE, Meline BS, et al. Comparative analysis of salivary bacterial microbiome diversity in edentulous infants and their mothers or primary care givers using pyrosequencing. PLoS One. 2011;6(8):e23503. doi:10.1371/journal.pone.0023503.
63. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96(3):544–51. doi:10.3945/ajcn.112.037382.
64. Collado MC, Isolauri E, Laitinen K, Salminen S. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92(5):1023–30. doi:10.3945/ajcn.2010.29877.
65. Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr. 2012;55(3):321–7. doi:10.1097/MPG.0b013e31824fb899.
66. Kavanaugh DW, O’Callaghan J, Buttó LF, Slattery H, Lane J, Clyne M, et al. Exposure of bifidobacterium longum subsp. infantis to milk oligosaccharides increases adhesion to epithelial cells and induces a substantial transcriptional response. PLoS One. 2013;8(6):e67224.
67. Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutri. 2012.
68. Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr. 2013. doi:10.1016/j.jpeds.2013.07.017.
69. Coppa GV, Gabrielli O, Pierani P, Catassi C, Carlucci A, Giorgi PL. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics. 1993;91(3):637–41.
70. Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, et al. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128(6):e1520–31.
71. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699–722.
72. Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, Ruhaak LR, et al. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res. 2012;11(12):6124–33.
73. Smilowitz JT, O’Sullivan A, Barile D, German JB, Lonnerdal B, Slupsky CM. The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013;143(11):1709–18. doi:10.3945/jn.113.178772.
74. Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL. Breast milk oligosaccharides: structure-function relationships in the neonate. Annu Rev Nutr. 2014;34:143–69. doi:10.1146/annurev-nutr-071813-105721.
75. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005;135(5):1304–7.
76. Reinhold V, Zhang H, Hanneman A, Ashline D. Toward a platform for comprehensive glycan sequencing. Mol Cell Proteomics. 2013;12(4):866–73. doi:10.1074/mcp.R112.026823.
77. Jantscher-Krenn E, Lauwaet T, Bliss LA, Reed SL, Gillin FD, Bode L. Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. Br J Nutr. 2012;108(10):1839–46. doi:10.1017/s0007114511007392.
78. Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, et al. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol. 2013;79(19):6040–9. doi:10.1128/aem.01843-13.
79. Bode L, Jantscher-Krenn E. Structure-function relationships of human milk oligosaccharides. Adv Nutr. 2012;3(3):383S–91. doi:10.3945/an.111.001404.
80. Maga EA, Desai PT, Weimer BC, Dao N, Kultz D, Murray JD. Consumption of lysozyme-rich milk can alter microbial fecal populations. Appl Environ Microbiol. 2012;78(17):6153–60. doi:10.1128/aem.00956-12.
81. Oda H, Wakabayashi H, Yamauchi K, Abe F. Lactoferrin and bifidobacteria. Biometals. 2014;27(5):915–22. doi:10.1007/s10534-014-9741-8.
82. Maga EA, Weimer BC, Murray JD. Dissecting the role of milk components on gut microbiota composition. Gut Microbes. 2013;4(2):136–9. doi:10.4161/gmic.23188.
83. Masschalck B, Michiels CW. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit Rev Microbiol. 2003;29(3):191–214. doi:10.1080/713610448.
84. Maga EA, Cullor JS, Smith W, Anderson GB, Murray JD. Human lysozyme expressed in the mammary gland of transgenic dairy goats can inhibit the growth of bacteria that cause mastitis and the cold-spoilage of milk. Foodborne Pathog Dis. 2006;3(4):384–92. doi:10.1089/fpd.2006.3.384.
85. McInnis EA, Kalanetra KM, Mills DA, Maga EA. Analysis of raw goat milk microbiota: impact of stage of lactation and lysozyme on microbial diversity. Food Microbiol. 2015;46:121–31. doi:10.1016/j.fm.2014.07.021.
86. Barboza M, Pinzon J, Wickramasinghe S, Froehlich JW, Moeller I, Smilowitz JT, et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol Cell Proteomics. 2012;11(6):M111 015248.
87. Aly E, Ros G, Frontela C. Structure and functions of lactoferrin as ingredient in infant formulas. J Food Res. 2013;2(4):25–36. doi:10.5539/jfr.v2n4p25.
88. Liu B, Newburg DS. Human milk glycoproteins protect infants against human pathogens. Breastfeed Med. 2013;8(4):354–62. doi:10.1089/bfm.2013.0016.
89. Wada Y, Lonnerdal B. Bioactive peptides derived from human milk proteins--mechanisms of action. J Nutr Biochem. 2014;25(5):503–14. doi:10.1016/j.jnutbio.2013.10.012.
90. Scarino ML. A sideways glance: take it or leave it? The role of lactoferrin in iron sequestration and delivery within the body. Genes Nutr. 2007;2(2):161–2. doi:10.1007/s12263-007-0054-1.
91. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci. 2005;62(22):2588–98. doi:10.1007/s00018-005-5373-z.
92. Actor JK, Hwang S-A, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des. 2009;15(17):1956–73.
93. Jenssen H, Hancock REW. Antimicrobial properties of lactoferrin. Biochimie. 2009;91(1):19–29. doi:10.1016/j.biochi.2008.05.015.
94. Wakabayashi H, Oda H, Yamauchi K, Abe F. Lactoferrin for prevention of common viral infections. J Infect Chemother. 2014;20(11):666–71. doi:10.1016/j.jiac.2014.08.003.
95. O’Riordan N, Gerlach JQ, Kilcoyne M, O’Callaghan J, Kane M, Hickey RM, et al. Profiling temporal changes in bovine milk lactoferrin glycosylation using lectin microarrays. Food Chem. 2014;165:388–96. doi:10.1016/j.foodchem.2014.05.086.
96. Fageras M, Tomicic S, Voor T, Bjorksten B, Jenmalm MC. Slow salivary secretory IgA maturation may relate to low microbial pressure and allergic symptoms in sensitized children. Pediatr Res. 2011;70(6):572–7.
97. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4(7):565–72. doi:10.1038/nri1393.
98. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77(6):1537S–43.
99. Moszynski P. Diarrhoeal diseases still kill more than 1.5m children under 5 each year. BMJ. 2007;335(7632):1227. doi:10.1136/bmj.39426.352685.
100. Mathias A, Longet S, Corthesy B. Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun. 2013;81(8):3027–34. doi:10.1128/iai.00303-13.
101. Klemm P, Schembri MA. Bacterial adhesins: function and structure. Int J Med Microbiol. 2000;290(1):27–35. doi:10.1016/s1438-4221(00)80102-2.
102. Perrier C, Sprenger N, Corthesy B. Glycans on secretory component participate in innate protection against mucosal pathogens. J Biol Chem. 2006;281(20):14280–7. doi:10.1074/jbc.M512958200.
103. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262(5141):1892–5.
104. Rogier EW, Frantz AL, Bruno MEC, Wedlund L, Cohen DA, Stromberg AJ, et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci. 2014;111(8):3074–9. doi:10.1073/pnas.1315792111.
105. Franca EL, Calderon Ide M, Vieira EL, Morceli G, Honorio-Franca AC. Transfer of maternal immunity to newborns of diabetic mothers. Clin Dev Immunol. 2012;2012:928187. doi:10.1155/2012/928187.
106. Morceli G, Franca EL, Magalhaes VB, Damasceno DC, Calderon IM, Honorio-Franca AC. Diabetes induced immunological and biochemical changes in human colostrum. Acta Paediatr. 2011;100(4):550–6. doi:10.1111/j.1651-2227.2010.02070.x.
107. Smilowitz JT, Totten SM, Huang J, Grapov D, Durham HA, Lammi-Keefe CJ, et al. Human milk secretory immunoglobulin a and lactoferrin N-glycans are altered in women with gestational diabetes mellitus. J Nutr. 2013;143(12):1906–12. doi:10.3945/jn.113.180695.